Hermine Agis Selected Research

felzartamab

5/2020

MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hermine Agis Research Topics

Disease

8	Multiple Myeloma 10/2022 - 01/2015
5	Neoplasms (Cancer) 04/2019 - 03/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2010 - 01/2002
4	Amyloidosis 12/2020 - 04/2019
4	Systemic Mastocytosis 04/2007 - 03/2005
3	Leukemia 10/2005 - 11/2002
2	Inflammation (Inflammations) 01/2021 - 01/2017
2	Immunoglobulin Light-chain Amyloidosis 01/2020 - 01/2017
2	Lymphoma (Lymphomas) 08/2017 - 07/2015
2	Blast Crisis (Blast Phase) 12/2006 - 01/2002
1	Cytokine Release Syndrome 03/2021
1	Smoldering Multiple Myeloma 01/2021
1	Residual Neoplasm 11/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2020
1	Cardiomyopathies (Cardiomyopathy) 07/2020
1	Polyneuropathies (Polyneuropathy) 07/2020
1	Transthyretin-Related Hereditary Amyloidosis 07/2020
1	Histiocytosis 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2019
1	Critical Illness (Critically Ill) 09/2019
1	Heart Failure 05/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Disease Progression 04/2018
1	Heart Diseases (Heart Disease) 04/2018
1	Atherosclerosis 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016
1	Refractory Anemia 03/2006
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2006
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2006
1	Refractory Anemia with Excess of Blasts (RAEM) 03/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2006
1	Polycythemia Vera 02/2006
1	Infections 02/2006
1	Primary Myelofibrosis (Myelosclerosis) 02/2006
1	Essential Thrombocythemia 02/2006
1	Mastocytosis 03/2005

Drug/Important Bio-Agent (IBA)

4	Prealbumin (Transthyretin)IBA 10/2020 - 04/2019
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2002
3	Imatinib Mesylate (Gleevec)FDA Link 12/2006 - 01/2002
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2021 - 09/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021 - 09/2019
2	Immunoglobulins (Immunoglobulin)IBA 03/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 05/2020
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2006 - 02/2006
2	ParaffinIBA 03/2006 - 02/2006
2	Biological ProductsIBA 02/2006 - 10/2005
1	belantamab mafodotinIBA 10/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 09/2021
1	Immunomodulating AgentsIBA 09/2021
1	Proteasome InhibitorsIBA 09/2021
1	daratumumabIBA 01/2021
1	SteroidsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2020
1	felzartamabIBA 05/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2019
1	Etoposide (VP 16)FDA LinkGeneric 09/2019
1	Interleukin-1 (Interleukin 1)IBA 09/2019
1	riociguatIBA 04/2019
1	FluoridesIBA 04/2019
1	ProteomeIBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 04/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2017
1	plerixafor FDA Link 08/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Complement System Proteins (Complement)IBA 10/2010
1	Oncogene Proteins (Oncogene Protein)IBA 01/2008
1	midostaurinIBA 04/2007
1	Antisense OligonucleotidesIBA 04/2007
1	bcr-abl Fusion ProteinsIBA 12/2006
1	Interferon-alpha (Interferon Alfa)IBA 12/2006
1	AntigensIBA 04/2006
1	Histidine DecarboxylaseIBA 04/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2006
1	Cytostatic AgentsIBA 02/2006
1	Tryptases (Tryptase)IBA 03/2005
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2002
1	Messenger RNA (mRNA)IBA 11/2002

Therapy/Procedure

7	Therapeutics 09/2021 - 01/2002
4	Stem Cell Transplantation 10/2018 - 07/2004
2	Critical Care (Surgical Intensive Care) 03/2021 - 01/2016
1	Artificial Respiration (Mechanical Ventilation) 03/2021
1	Transplantation 01/2021
1	Hematopoietic Stem Cell Mobilization 08/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Hematopoietic Stem Cell Transplantation 01/2015
1	Consolidation Chemotherapy 02/2006
1	Homologous Transplantation 07/2004